Identification of melanoma cells by formaldehyde-induced fluorescence

Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Journal of microscopy·2014

Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2009

Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Journal of microscopy·2008

Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.

Gene therapy·2004

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.

Gene therapy·2002

Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

Journal of neuro-oncology·2002

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

Cancer·2026

Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

Cancer·2026

The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

Cancer·2026

Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

Cancer·2026

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

Cancer·2026

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Cancer·2026

Skeletal muscle invasion identifies aggressive merkel cell carcinomas beyond tumor size-based risk stratification: a tertiary cancer center experience.

Virchows Archiv : an international journal of pathology·2026

EWSR1::ATF7 fusion driven mesenchymal neoplasm with rhabdomyoblastic differentiation.

Virchows Archiv : an international journal of pathology·2026

[Melanoma - an overview of the disease and its treatment].

Therapeutische Umschau. Revue therapeutique·2026

A macrophage-conditioned medium model recapitulates inflammation-associated suppression of UCP-1 expression in KK-Ay mice.

Bioscience, biotechnology, and biochemistry·2026

Expanding the scope of Mycobacterium abscessus reference strains to improve pulmonary disease modeling.

Disease models & mechanisms·2026

[Research progress on mitochondrial dysfunction in multiple myeloma].

Sheng li xue bao : [Acta physiologica Sinica]·2026

Related Experiment Videos

Identification of melanoma cells by formaldehyde-induced fluorescence

Related Concept Videos

Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.

Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.

Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Skeletal muscle invasion identifies aggressive merkel cell carcinomas beyond tumor size-based risk stratification: a tertiary cancer center experience.

EWSR1::ATF7 fusion driven mesenchymal neoplasm with rhabdomyoblastic differentiation.

[Melanoma - an overview of the disease and its treatment].

A macrophage-conditioned medium model recapitulates inflammation-associated suppression of UCP-1 expression in KK-Ay mice.

Expanding the scope of Mycobacterium abscessus reference strains to improve pulmonary disease modeling.

[Research progress on mitochondrial dysfunction in multiple myeloma].

Related Experiment Videos

Identification of melanoma cells by formaldehyde-induced fluorescence

Related Concept Videos

Related Articles